missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
Invitrogen™ Human LRRTM3 Synthetic Peptide
Beskrivning
LRRTM3 Synthetic Peptide, PEP-1212, from Invitrogen.
The Leucine-rich repeat transmembrane neuronal proteins (LRRTMs) are differentially expressed in the nervous system and were recently found to instruct presynaptic and mediate postsynaptic glutamatergic differentiation, with LRRTM1 and LRRTM2 most potent at inducing presynaptic differentiation. Recent evidence suggests that LRRTM3 promotes the processing of amyloid-precursor protein (APP) by the beta-secretase BACE, leading to the proteolytic production of the A-beta42 peptide that is the main component of amyloid plaques. Furthermore, LRRTM3 maps to a region of chromosome 10 linked to both late-onset Alzheimer's disease (AD) and elevated plasma A-beta42 levels, suggesting that LRRTM3 is a functional and positional candidate gene for AD.
Specifikationer
Specifikationer
| Gen-ID (Entrez) | 347731 |
| Art | Human |
| Reningsmetod | purified |
| Tillträdesnummer | Q86VH5 |
| Vanligt namn | Human LRRTM3 |
| Koncentration | 200 μg/mL |
| Innehåll och lagring | -20°C |
| Beskrivning | Synthetic Peptide |
| Formatera | Liquid |
| Formulering | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Visa mer |
Produkttitel
Genom att klicka på Skicka bekräftar du att du kan bli kontaktad av Fisher Scientific angående feedbacken du har lämnat i detta formulär. Vi kommer inte att dela din information för andra ändamål. All kontaktinformation som tillhandahålls ska också underhållas i enlighet med vår Sekretesspolicy.
Hittar du en möjlighet till förbättring?